Patients with ovarian cancer may receive intraperitoneal (IP) chemotherapy, which delivers chemotherapeutic agents directly into the peritoneal cavity. Drugs given by this route include paclitaxel, carboplatin, and cisplatin.
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.